Viruses Vaccines And Antivirals Why Politics Matters

This short book brings together novel cross-interdisciplinary investigation from both natural and social science, representing a true hybrid across disciplines examining the ‘politics’ and ‘science’ of COVID-19. Viruses, Vaccines, and Antivirals: Why Politics Matters considers the dynamics surrounding viruses, proposed vaccines, and antiviral therapies, contextualizing what governments have done during the COVID-19 crisis. The four basic phases of a pandemic are considered with a strong focus on COVID-19, namely the anticipating and early virus detection, containment strategies, policies to control and mitigate the spread of the virus and policies aimed at opening up society. Viruses, Vaccines, and Antivirals: Why Politics Matters examines policy developments throughout these phases in key nations worldwide and puts forward a blueprint for countries developing public policies to deal with a pandemic.

Pandemic policies have been the focus of fierce lobbying competition by different social and economic interests. In Viral Lobbying a team of expert authors from across the social and natural sciences analyse patterns in and implications of this ‘viral lobbying’. Based on elite surveys and focus group interviews with selected groups, the book provides new evidence on the lobbying strategies used during the COVID 19 pandemic, as well as the resulting access to and lobbying influence on public policy. The empirical analyses reach across eight European countries (Austria, Denmark, Germany, Ireland, Italy, the Netherlands, Sweden, United Kingdom), as well as the EU-level. In particular, the book draws on responses from approximately 1,600 interest organisations in two waves of a cross-country survey (in 2020 and 2021, respectively). This quantitative data is supplemented by qualitative evidence from a series of 12 focus groups with organised interests in Ireland, Denmark and the Netherlands conducted in spring 2021.

This book is a collection of chapters dealing with examples of RNA and DNA viruses, and issues such as how these gene packages have learnt to take advantage of their hosts, molecular recognition events that hosts may use to counterattack the viruses, and how researchers have developed strategies to use viruses or their parts as tools for different purposes.

The Secret in Medieval Literature explores the many secret agents, actions, creatures, and other beings influencing human existence. Medieval poets had a clear sense of the alternative dimension (the secret) and allowed it to enter quite frequently into their texts.

Corona, the Lockdown, and the Media investigates media influence on policies to contain the COVID-19 pandemic. Bernhagen and Kybelka propose that news reporting on the pandemic pitches human impact against economic consequences of the virus and of restrictive policy measures designed to contain it. They argue that the use of these frames influences governments’ decisions to enact or lift lockdown measures. Using time series data from England, France, and Germany, the authors show that news reporting on COVID-19 was indeed characterized by these media frames. However, there is no evidence of media influence on government policy. Instead, the authors find that anti-pandemic policy decisions were responsive to public opinion in these countries.

In March and early April 2009, a new, swine-origin 2009-H1N1 influenza A virus emerged in Mexico and the United States. During the first few weeks of surveillance, the virus spread by human-to-human transmission worldwide to over 30 countries. On June 11, 2009, the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 6 in response to the ongoing global spread of the novel influenza A (H1N1) virus. By October 30, 2009, the H1N1 influenza A had spread to 191 countries and resulted in 5,700 fatalities. A national emergency was declared in the United States and the swine flu joined SARS and the avian flu as pandemics of the 21st century. Vaccination is currently available, but in limited supply, and with a 60 percent effectiveness rate against the virus. The story of how this new influenza virus spread out of Mexico to other parts of North America and then on to Europe, the Far East, and now Australia and the Pacific Rim countries has its origins in the global interconnectedness of travel, trade, and tourism. Given the rapid spread of the virus, the international scientific, public health, security, and policy communities had to mobilize quickly to characterize this unique virus and address its potential effects. The World Health Organization and Centers for Disease Control have played critical roles in the surveillance, detection and responses to the H1N1 virus. The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions aimed to examine the evolutionary origins of the H1N1 virus and evaluate its potential public health and socioeconomic consequences, while monitoring and mitigating the impact of a fast-moving pandemic. The rapporteurs for this workshop reported on the need for increased and geographically robust global influenza vaccine production capacities; enhanced and sustained interpandemic demand for seasonal influenza vaccines; clear "triggers" for pandemic alert levels; and accelerated research collaboration on new vaccine manufacturing techniques. This book will be an essential guide for healthcare professionals, policymakers, drug manufacturers and investigators.

As the culminating volume in the DCP3 series, volume 9 will provide an overview of DCP3 findings and methods, a summary of messages and substantive lessons to be taken from DCP3, and a further discussion of cross-cutting and synthesizing topics across the first eight volumes. The introductory chapters (1-3) in this volume take as their starting point the elements of the Essential Packages presented in the overview chapters of each volume. First, the chapter on intersectoral policy priorities for health includes fiscal and intersectoral policies and assembles a subset of the population policies and applies strict criteria for a low-income setting in order to propose a "highest-priority" essential package. Second, the chapter on packages of care and delivery platforms for universal health coverage (UHC) includes health sector interventions, primarily clinical and public health services, and uses the same approach to propose a highest priority package of interventions and policies that meet similar criteria, provides cost estimates, and describes a pathway to UHC.

This guidance is an update of WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics, published March 2005 (WHO/CDS/CSR/GIP/2005.5).